Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -8.06% vs 20.96% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 5.83% vs 31.19% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 2.73% vs 15.68% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 12.25% vs 484.68% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Imexpharm Corp. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -14.76% vs 11.72% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -8.06% vs 20.96% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -32.02% vs 62.55% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.83% vs 31.19% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -21.85% vs 24.45% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 2.73% vs 15.68% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -21.63% vs -36.27% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 12.25% vs 484.68% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






